Impact of Spondyloarthritis on Pregnancy Outcome: A Descriptive Analysis from a Specialized Center in Qatar

Samar Al Emadi,1 Nawal Nouman Hadwan,1 Rawan Saleh,1 Eman Satti,1 Rajvir Singh2 1Department of Rheumatology, Hamad Medical Corporation, Doha, Qatar; 2Medical Research Center, Statistics, Hamad Medical Corporation, Doha, QatarCorrespondence: Samar Al Emadi, Department of Rheumatology, Hamad General H...

Full description

Bibliographic Details
Main Authors: Al Emadi S, Hadwan NN, Saleh R, Satti E, Singh R
Format: Article
Language:English
Published: Dove Medical Press 2024-01-01
Series:Open Access Rheumatology: Research and Reviews
Subjects:
Online Access:https://www.dovepress.com/impact-of-spondyloarthritis-on-pregnancy-outcome-a-descriptive-analysi-peer-reviewed-fulltext-article-OARRR
_version_ 1797348229118951424
author Al Emadi S
Hadwan NN
Saleh R
Satti E
Singh R
author_facet Al Emadi S
Hadwan NN
Saleh R
Satti E
Singh R
author_sort Al Emadi S
collection DOAJ
description Samar Al Emadi,1 Nawal Nouman Hadwan,1 Rawan Saleh,1 Eman Satti,1 Rajvir Singh2 1Department of Rheumatology, Hamad Medical Corporation, Doha, Qatar; 2Medical Research Center, Statistics, Hamad Medical Corporation, Doha, QatarCorrespondence: Samar Al Emadi, Department of Rheumatology, Hamad General Hospital, PO Box 3050, Doha, Qatar, Tel +974 55550087, Email salemadi@hamad.qaIntroduction: Spondyloarthritis (SpA) most commonly presents at childbearing age; thus, pregnancy is of concern. However, data on pregnancy outcomes in these patients are limited.Purpose: This study aimed to retrospectively describe pregnancy outcomes in patients with SpA from the Middle East.Patients and Methods: We reviewed the electronic health records of all pregnant women attending a specialized pregnancy and rheumatic disease clinic between 2016 and 2022. All pregnant patients diagnosed with axial spondyloarthritis (axSpA) and peripheral SpA were included. Data on adverse maternal and fetal outcomes were collected.Results: Fifty-seven eligible pregnancies were identified from hospital records: 10 pregnancies ended in early miscarriage. Forty-seven pregnancies resulted in live singleton births, 25 in patients with peripheral SpA and 22 with axSpA. Human leukocyte antigen B27 was positive in 7 (15%) patients and only in women with axSpA. Twenty-nine (64%) patients received treatment throughout pregnancy. Consistent biologic disease-modifying antirheumatic drug (bDMARD) use was high, in eight (32%) patients with peripheral SpA and in nine (41%) with axSpA. A conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) was used as treatment in 11 (50%) patients with peripheral SpA and two (8%) with axSpA. Twenty-two (53%) neonates were delivered by cesarean section, 19 (40%) by normal vaginal delivery and three (6%) by assisted delivery. Additionally, 44 (94%) deliveries were at term, and 42 (91%) neonates had a normal birth weight. Exploration of a subgroup showed no difference in reported outcomes between patients treated with bDMARD and those treated with csDMARD.Conclusion: This descriptive study reports a high rate of favorable pregnancy outcomes in patients with SpA. There was no evidence to suggest a difference in pregnancy outcomes between women with axSpA and those with peripheral SpA. This study was one of the first reports from the Middle East. Further studies with larger sample size are warranted.Keywords: axial spondyloarthritis, pregnancy, pregnancy outcomes, neonatal health, maternal health
first_indexed 2024-03-08T12:01:43Z
format Article
id doaj.art-8c56bb00b6ba43a58d4416e3e11e946f
institution Directory Open Access Journal
issn 1179-156X
language English
last_indexed 2024-03-08T12:01:43Z
publishDate 2024-01-01
publisher Dove Medical Press
record_format Article
series Open Access Rheumatology: Research and Reviews
spelling doaj.art-8c56bb00b6ba43a58d4416e3e11e946f2024-01-23T18:27:27ZengDove Medical PressOpen Access Rheumatology: Research and Reviews1179-156X2024-01-01Volume 16212989884Impact of Spondyloarthritis on Pregnancy Outcome: A Descriptive Analysis from a Specialized Center in QatarAl Emadi SHadwan NNSaleh RSatti ESingh RSamar Al Emadi,1 Nawal Nouman Hadwan,1 Rawan Saleh,1 Eman Satti,1 Rajvir Singh2 1Department of Rheumatology, Hamad Medical Corporation, Doha, Qatar; 2Medical Research Center, Statistics, Hamad Medical Corporation, Doha, QatarCorrespondence: Samar Al Emadi, Department of Rheumatology, Hamad General Hospital, PO Box 3050, Doha, Qatar, Tel +974 55550087, Email salemadi@hamad.qaIntroduction: Spondyloarthritis (SpA) most commonly presents at childbearing age; thus, pregnancy is of concern. However, data on pregnancy outcomes in these patients are limited.Purpose: This study aimed to retrospectively describe pregnancy outcomes in patients with SpA from the Middle East.Patients and Methods: We reviewed the electronic health records of all pregnant women attending a specialized pregnancy and rheumatic disease clinic between 2016 and 2022. All pregnant patients diagnosed with axial spondyloarthritis (axSpA) and peripheral SpA were included. Data on adverse maternal and fetal outcomes were collected.Results: Fifty-seven eligible pregnancies were identified from hospital records: 10 pregnancies ended in early miscarriage. Forty-seven pregnancies resulted in live singleton births, 25 in patients with peripheral SpA and 22 with axSpA. Human leukocyte antigen B27 was positive in 7 (15%) patients and only in women with axSpA. Twenty-nine (64%) patients received treatment throughout pregnancy. Consistent biologic disease-modifying antirheumatic drug (bDMARD) use was high, in eight (32%) patients with peripheral SpA and in nine (41%) with axSpA. A conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) was used as treatment in 11 (50%) patients with peripheral SpA and two (8%) with axSpA. Twenty-two (53%) neonates were delivered by cesarean section, 19 (40%) by normal vaginal delivery and three (6%) by assisted delivery. Additionally, 44 (94%) deliveries were at term, and 42 (91%) neonates had a normal birth weight. Exploration of a subgroup showed no difference in reported outcomes between patients treated with bDMARD and those treated with csDMARD.Conclusion: This descriptive study reports a high rate of favorable pregnancy outcomes in patients with SpA. There was no evidence to suggest a difference in pregnancy outcomes between women with axSpA and those with peripheral SpA. This study was one of the first reports from the Middle East. Further studies with larger sample size are warranted.Keywords: axial spondyloarthritis, pregnancy, pregnancy outcomes, neonatal health, maternal healthhttps://www.dovepress.com/impact-of-spondyloarthritis-on-pregnancy-outcome-a-descriptive-analysi-peer-reviewed-fulltext-article-OARRRaxial spondyloarthritispregnancypregnancy outcomesneonatal healthmaternal health  
spellingShingle Al Emadi S
Hadwan NN
Saleh R
Satti E
Singh R
Impact of Spondyloarthritis on Pregnancy Outcome: A Descriptive Analysis from a Specialized Center in Qatar
Open Access Rheumatology: Research and Reviews
axial spondyloarthritis
pregnancy
pregnancy outcomes
neonatal health
maternal health  
title Impact of Spondyloarthritis on Pregnancy Outcome: A Descriptive Analysis from a Specialized Center in Qatar
title_full Impact of Spondyloarthritis on Pregnancy Outcome: A Descriptive Analysis from a Specialized Center in Qatar
title_fullStr Impact of Spondyloarthritis on Pregnancy Outcome: A Descriptive Analysis from a Specialized Center in Qatar
title_full_unstemmed Impact of Spondyloarthritis on Pregnancy Outcome: A Descriptive Analysis from a Specialized Center in Qatar
title_short Impact of Spondyloarthritis on Pregnancy Outcome: A Descriptive Analysis from a Specialized Center in Qatar
title_sort impact of spondyloarthritis on pregnancy outcome a descriptive analysis from a specialized center in qatar
topic axial spondyloarthritis
pregnancy
pregnancy outcomes
neonatal health
maternal health  
url https://www.dovepress.com/impact-of-spondyloarthritis-on-pregnancy-outcome-a-descriptive-analysi-peer-reviewed-fulltext-article-OARRR
work_keys_str_mv AT alemadis impactofspondyloarthritisonpregnancyoutcomeadescriptiveanalysisfromaspecializedcenterinqatar
AT hadwannn impactofspondyloarthritisonpregnancyoutcomeadescriptiveanalysisfromaspecializedcenterinqatar
AT salehr impactofspondyloarthritisonpregnancyoutcomeadescriptiveanalysisfromaspecializedcenterinqatar
AT sattie impactofspondyloarthritisonpregnancyoutcomeadescriptiveanalysisfromaspecializedcenterinqatar
AT singhr impactofspondyloarthritisonpregnancyoutcomeadescriptiveanalysisfromaspecializedcenterinqatar